PhRMA, a lobbying group for pharmaceutical companies, called the proposal “price controls” and said it was “disappointed the administration put the needs of patients aside with these proposals.” There will likely be escalating pushback from the industry against the new proposal intended to curb high drug prices.
from Kaiser Health News https://ift.tt/2z364PZ
October 26, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Health Care Ranks At The Top Of Americans’ Financial WoesThe Gallup poll found that older Americans especially ranked health care as their top issue. High costs are likely to come into play in the 2020 election. from Kaiser Health News http://bit.ly/2Kf0wJf … Read More
Third Conservative House Republican Derails Disaster Aid, Keeping Its Fate In Limbo Until Recess BreaksThe objection was voiced by freshman Rep. John Rose (R-Tenn.) after Democrats sought to advance the legislation via unanimous consent. The package has faced many road bumps in the past few months, and is meant to help the vic… Read More
Increase In Chest Binding Among Gender-Variant Teens Brings Warnings About Potential Negative Health EffectsWhile many transgender teens wear breast compression devices to diminish feelings of discomfort known as body dysphoria, they can be creating problems such as breathing difficulties and overheating, physicians warn. In other … Read More
Minnesota To Hit Opioid Makers With Moderate Licensing Fees To Collect Money To Combat Epidemic In State“This is unusual,” said Carmen Catizone, executive director of the National Association of Boards of Pharmacy. “We keep seeing the states trying to find new ways to finance the costs of the opioid crisis. But this is a new an… Read More
Chicago Nursing Home Debacle Highlights Flaws In HUD Program That’s Become Linchpin Of Country’s Elder-Care SystemThe New York Times looks at what went wrong with Rosewood Care Centers, and how the program it relied on is a dangerous vulnerable spot for the federal government. from Kaiser Health News http://bit.ly/2Kf0u45 … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment